capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis
The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare.
135
views

The concept of BBB penetration is anticipatedto bring about a paradigm shift in modern healthcare. In fact, experts believethat there is an important relationship between the recent pandemic ofCoronavirus disease (COVID-19) and cerebrovascular system, presentingcommercial opportunities for players engaged in the development of BBBpenetrating drugs.

 

Toorder this 400+ page report, which features 145+ figures and 205+ tables,please visit this -https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html

 

The USD 940 million (by 2030) financial opportunitywithin the BBB market has been analyzed across the following segments:

§ Type of Payment ModelAdopted

§ Upfront payments

§ Milestone payments

 

§ Type of Molecule

§ Small Molecules

§ Biologics

 

§ Target Disease Indication

§ Brain Metastases inBreast Cancer

§ GlioblastomaMultiforme

§ Hunter Syndrome

§ Hurler Syndrome

 

§ Leading TechnologyPlatforms

§ G®-Technology

§ J-Brain Cargo®Technology

§ LRP-1 Technology

§ Trojan HorseTechnology

 

§ Leading DrugDevelopers

§ 2-BBB

§ Angiochem

§ ArmaGen

§ JCR Pharmaceuticals

 

§ Key GeographicalRegions

§ North America

§ Europe

§ Asia-Pacific

 

 

The Blood-BrainBarrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-InvasiveDrug Delivery Technology Platforms and Therapeutics.”

 report features thefollowing companies, which we identified to be key players in this domain:

§ Angiochem

§ ArmaGen

§ BioArctic

§ Cyclenium Pharma

§ Denali Therapeutics

§ ICB International

§ Iproteos

§ JCR Pharmaceuticals

§ Lauren Sciences

§ Medesis Pharma

§ Ossianix

§ Vect-Horus

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape: Non-Invasive BBB Penetration

5. Market Landscape: BBB Penetrating Drugs

6. Company Profiles

7. Technology Competitiveness Analysis 

8. Non-Invasive BBB Penetration Technologies: PopularApproaches


9. Partnershipsand Collaborations

10. Analysis of Recent Licensing Agreements

11. Funding and Investment Analysis

12. Patent Analysis

13. Drug Development Strategy Analysis

14. Market Potential of Key Neurological Disorders

 

15. Likely Partner Analysis

 

16. Market Forecast

 

17. Conclusion

 

18. Executive Insights

 

19. Appendix 1: Tabulated Data

 

20. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com